Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions
- PMID: 29301327
- PMCID: PMC5872031
- DOI: 10.3390/biology7010005
Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions
Abstract
DNA polymerases are essential for genome replication, DNA repair and translesion DNA synthesis (TLS). Broadly, these enzymes belong to two groups: replicative and non-replicative DNA polymerases. A considerable body of data suggests that both groups of DNA polymerases are associated with cancer. Many mutations in cancer cells are either the result of error-prone DNA synthesis by non-replicative polymerases, or the inability of replicative DNA polymerases to proofread mismatched nucleotides due to mutations in 3'-5' exonuclease activity. Moreover, non-replicative, TLS-capable DNA polymerases can negatively impact cancer treatment by synthesizing DNA past lesions generated from treatments such as cisplatin, oxaliplatin, etoposide, bleomycin, and radiotherapy. Hence, the inhibition of DNA polymerases in tumor cells has the potential to enhance treatment outcomes. Here, we review the association of DNA polymerases in cancer from the A and B families, which participate in lesion bypass, and conduct gene replication. We also discuss possible therapeutic interventions that could be used to maneuver the role of these enzymes in tumorigenesis.
Keywords: 3′-5′ exonuclease; DNA polymerase; DNA polymerase and cancer; base excision repair; cancer; mismatch repair; replication fork; therapy for mismatch repair deficient cancers; translesion DNA synthesis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Filling gaps in translesion DNA synthesis in human cells.Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt B):127-142. doi: 10.1016/j.mrgentox.2018.02.004. Epub 2018 Feb 23. Mutat Res Genet Toxicol Environ Mutagen. 2018. PMID: 30442338 Review.
-
Translesion and Repair DNA Polymerases: Diverse Structure and Mechanism.Annu Rev Biochem. 2018 Jun 20;87:239-261. doi: 10.1146/annurev-biochem-062917-012405. Epub 2018 Mar 1. Annu Rev Biochem. 2018. PMID: 29494238 Free PMC article. Review.
-
Specificity of platinum-DNA adduct repair.J Inorg Biochem. 1999 Oct;77(1-2):71-81. doi: 10.1016/s0162-0134(99)00149-x. J Inorg Biochem. 1999. PMID: 10626357
-
Freedom to err: The expanding cellular functions of translesion DNA polymerases.Mol Cell. 2023 Oct 19;83(20):3608-3621. doi: 10.1016/j.molcel.2023.07.008. Epub 2023 Aug 24. Mol Cell. 2023. PMID: 37625405 Review.
-
Translesion synthesis in Escherichia coli: lessons from the NarI mutation hot spot.DNA Repair (Amst). 2007 Jul 1;6(7):1032-41. doi: 10.1016/j.dnarep.2007.02.021. Epub 2007 Apr 2. DNA Repair (Amst). 2007. PMID: 17403618 Review.
Cited by
-
Altered immunoexpression of DNA polymerase delta 1 catalytic subunit (POLD1) in colorectal cancer.Contemp Oncol (Pozn). 2023;27(3):147-154. doi: 10.5114/wo.2023.133505. Epub 2023 Dec 6. Contemp Oncol (Pozn). 2023. PMID: 38239863 Free PMC article.
-
Current perspectives on mechanisms of ribonucleotide incorporation and processing in mammalian DNA.Genes Environ. 2019 Jan 25;41:3. doi: 10.1186/s41021-019-0118-7. eCollection 2019. Genes Environ. 2019. PMID: 30700998 Free PMC article. Review.
-
When DNA Polymerases Multitask: Functions Beyond Nucleotidyl Transfer.Front Mol Biosci. 2022 Jan 7;8:815845. doi: 10.3389/fmolb.2021.815845. eCollection 2021. Front Mol Biosci. 2022. PMID: 35071329 Free PMC article. Review.
-
Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells.Mol Med Rep. 2021 Sep;24(3):629. doi: 10.3892/mmr.2021.12268. Epub 2021 Jul 19. Mol Med Rep. 2021. PMID: 34278473 Free PMC article.
-
Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era.Int J Mol Sci. 2024 Apr 8;25(7):4113. doi: 10.3390/ijms25074113. Int J Mol Sci. 2024. PMID: 38612922 Free PMC article. Review.
References
-
- Bessman M.J., Kornberg A., Lehman I.R., Simms E.S. Enzymic synthesis of deoxyribonucleic acid. Biochim. Biophys. Acta. 1956;21:197–198. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous